BioXcel Therapeutics

BTAINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$27.842 M

$0.90 +8.61%

Close of 7 Aug 2026

Revenue

$642.0K

#3533 by revenue

Earnings

-$69.9M

Loss-making

Shares outstanding

27,074,586

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#378Rockwell MedicalRMTI$28.2M
#379Universe PharmaceuticalsUPC$27.9M
#380BioXcel TherapeuticsBTAI$27.8M
#381Abvc BiopharmaABVC$27.1M
#382Actuate TherapeuticsACTU$26.4M

Where these numbers come from

Share counts and financials for BioXcel Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.